As posted in the ASCO Daily News, Dr. George Demetri, has received recognition for his work in developing targeted TKIs for GIST.
A few weeks ago, Chris Carley lost his battle with GIST and the Life Raft Group lost one of its heroes. He was 73 and had been fighting his battle with GIST since 1995. He [...]
David Josephy On behalf of The Life Raft Group USA and Life Raft Group Canada, I attended the Sarcoma & GIST 2016 meeting organized by the European Society for Medical Oncology (ESMO) [...]
In a recent release from the Translational Genomics Research Institute (TGen), it was reported that researchers have discovered that by analyzing circulating tumor DNA (ctDNA) through liquid biopsy that a patient's cancer can be tracked [...]
It has been a long journey since that day Melinda and I walked out of my Dallas oncologist’s office in May, 2000 knowing that I had a rare, then untreatable cancer. Now, it has [...]
A presentation to commemorate the 2nd Annual GIST Awareness Day The Life Raft Group hosted a distinguished panel of experts on GIST Awareness Day to share their knowledge in areas of GIST treatment and management. This [...]
As personalized medicine has become an accepted paradigm, it may be time for oncologists to examine personalized dose levels.In a recent article from Cancer World, the author explores the value of therapeutic drug monitoring for [...]
At the recent American Society of American Oncology Meeting (ASCO), Dr. George Demetri, Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, presented results from a collaborative trial that indicates in [...]
Here is a video of Dr. George Demetri speaking about GIST in 2010.
Honorary chair Dr. George Demetri at Life Fest 2010.